A team of the INSERM research center in Toulouse Cancer found that removing a specific enzyme, the progression of pancreatic cancer could be curbed.
This discovery opens a promising avenue for the treatment of pancreatic cancer.
The elimination of an enzyme reduced the progression of cancer
Pierre Cordelier, Research Director at the Toulouse Cancer Research Center, working for several years on an enzyme called cytidine deaminase (CDA).
As to his research, he discovered that his amendment allowed to sensitize cancer cells to chemotherapy. He also realized that by eliminating it, the proliferation of cancer cells was reduced significantly without even follow chemotherapy.
Pancreatic cancer: treatment within 5 to 10 years
"CDA is believed that removing was only helping chemotherapy. But this is totally unexpected is that in eliminating the tumor progression is blocked," says Pierre Cordelier. The researcher believes that the discovery opens up the possibility of treatment but who certainly could not see the day before five to ten years.
Pancreatic cancer recorded 13,000 cases each year in France. The survival rate at 5 years for people with this cancer is only 8%.
0 commentaires :
Post a Comment